Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
5Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Northwest Biotherapeutics, Inc. (NWBO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
13Total relationships
3Distinct source URLs
6High confidence
0.766Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Northwest Biotherapeutics, Inc. Suppliers
Ticker
Name
Confidence
Evidence
ADVENT-BIOSERVICES-LTD
ADVENT-BIOSERVICES-LTD
92%
Prior to the acquisition, Advent provided the Company with product development, manufacturing, cryostorage and distribution services for the Company’s DCVax® product platform pursuant to various serv…
TOUCAN-HOLDINGS-LLC
TOUCAN-HOLDINGS-LLC
90%
the acquisition of Advent BioServices Ltd. ("Advent"), a United Kingdom-based contract development and manufacturing organization (CDMO), from Toucan Holdings LLC (the "Seller")
Reciprocal relationship from MRK graph: Reciprocal relationship from NWBO graph: been developed in 2023. The Company has determined that the smaller prototype will be preferable, to enable more units…
been developed in 2023. The Company has determined that the smaller prototype will be preferable, to enable more units to fit in each manufacturing lab. Production of the GMP-grade units will be time…
Northwest Biotherapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
CANACCORD-GENUITY-LLC-CITADEL-SECURITIES-LLC
CANACCORD-GENUITY-LLC-CITADEL-SECURITIES-LLC
62%
ugh regular vulnerability scans, penetration tests and threat intelligence feeds. We require third-party service providers with access to personal, confidential or proprietary information to implemen…
FLASKWORKS-NORTHWEST-BIOTHERAPEUTICS-LIMITED
FLASKWORKS-NORTHWEST-BIOTHERAPEUTICS-LIMITED
62%
eviewed the fair value models used, significant assumptions, and underlying data used in the models and evaluated whether the estimates and assumptions were consistent with audit evidence obtained. ●…
LIME-TRADING-CORP
LIME-TRADING-CORP
62%
ugh regular vulnerability scans, penetration tests and threat intelligence feeds. We require third-party service providers with access to personal, confidential or proprietary information to implemen…
TOUCAN-HOLDINGS-LLC
TOUCAN-HOLDINGS-LLC
62%
d in Note 14. As consideration for entering the 2024 Two-Year Dual Convertible Notes, the Company also agreed to amend certain existing warrants to extend the term of the warrant maturity date for an…
VIRTU-AMERICAS-LLC
VIRTU-AMERICAS-LLC
62%
ugh regular vulnerability scans, penetration tests and threat intelligence feeds. We require third-party service providers with access to personal, confidential or proprietary information to implemen…
Northwest Biotherapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NWBO-DEBT-11440
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
NWBO-DEBT-11439
Warrants outstanding: 200000
90%
xbrl warrant detail from xbrl 2025-12-31.
NWBO-DEBT
Debt stack $54.1M
90%
Market cache reports total debt of $54.1M.
Northwest Biotherapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Northwest Biotherapeutics, Inc..
Northwest Biotherapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
NWBO-OWNER-KELLEHER-FINANCIAL-ADVISORS
KELLEHER FINANCIAL ADVISORS
90%
13F overlay lists KELLEHER FINANCIAL ADVISORS as top holder; 8 tracked holders.
Northwest Biotherapeutics, Inc. Extended Supply Chain Network
